Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Non-complex distal LM bifurcation disease requiring percutaneous coronary intervention. 2. Unprotected left main 3. Patient >=18 years old and willing to participate in the trial
Exclusion criteria
Exclusion criteria: 1. Complex LM bifurcation disease requiring upfront two-stent strategy. 2. Patients previously underwent CABG 3. Patients who underwent previously stenting to LM to LAD or LCX 4. Allergic to antiplatelets (Aspirin, Clopidogrel, Ticagrelor, Prasugrel) or unable to use dual antiplatelet therapy (DAPT) 5. Life expectancy less than 1 year 6. Patient unable to give informed consent 7. Women of child-bearing potential or lactating
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint of the study will be angiographically significant stenosis (greater than 50 percent stenosis by visual estimation) at the end of one year.Timepoint: At the end of one year. | — |
Secondary
| Measure | Time frame |
|---|---|
| A composite of cardiac death, non-fatal myocardial infarction or target vessel failure at the end of 1 year. Other secondary end points include target vessel failure, stent thrombosis.Timepoint: 1 year | — |
Countries
India
Contacts
Army Institute of Cardio Thoracic Sciences